FRESENIUS SE & CO KGAA (FRE.DE) Fundamental Analysis & Valuation

FRA:FRE • DE0005785604

Current stock price

43.58 EUR
-0.37 (-0.84%)
Last:

This FRE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FRE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FRE was profitable.
  • In the past year FRE had a positive cash flow from operations.
  • FRE had positive earnings in 4 of the past 5 years.
  • FRE had a positive operating cash flow in 4 of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • With a Return On Assets value of 2.69%, FRE perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
  • The Return On Equity of FRE (6.14%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 4.44%, FRE is in line with its industry, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 4.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Profit Margin of FRE (5.11%) is better than 86.21% of its industry peers.
  • In the last couple of years the Profit Margin of FRE has grown nicely.
  • FRE's Operating Margin of 9.76% is amongst the best of the industry. FRE outperforms 86.21% of its industry peers.
  • In the last couple of years the Operating Margin of FRE has declined.
  • The Gross Margin of FRE (24.99%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. FRE.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
  • FRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.00 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FRE's Altman-Z score of 2.00 is fine compared to the rest of the industry. FRE outperforms 68.97% of its industry peers.
  • The Debt to FCF ratio of FRE is 11.17, which is on the high side as it means it would take FRE, 11.17 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of FRE (11.17) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.61, FRE belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2
ROIC/WACC0.85
WACC5.2%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • FRE's Current ratio of 1.26 is fine compared to the rest of the industry. FRE outperforms 65.52% of its industry peers.
  • A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
  • With a decent Quick ratio value of 0.99, FRE is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. FRE.DE Growth Analysis

3.1 Past

  • FRE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.31%.
  • Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.06% on average per year.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 3.87% in the last year.
  • The Revenue has been decreasing by -8.81% on average over the past years.
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.54% on average over the next years. This is quite good.
  • FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.03% yearly.
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue Next Year4.95%
Revenue Next 2Y4.9%
Revenue Next 3Y5.06%
Revenue Next 5Y5.03%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. FRE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.62, the valuation of FRE can be described as correct.
  • Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 72.41% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, FRE is valued a bit cheaper.
  • FRE is valuated reasonably with a Price/Forward Earnings ratio of 11.72.
  • FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 68.97% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.84, FRE is valued a bit cheaper.
Industry RankSector Rank
PE 13.62
Fwd PE 11.72
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 65.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.47
EV/EBITDA 9.67
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y13.43%
EPS Next 3Y11.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. FRE.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.38%, FRE has a reasonable but not impressive dividend return.
  • FRE's Dividend Yield is a higher than the industry average which is at 1.77.
  • Compared to an average S&P500 Dividend Yield of 1.88, FRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRE.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (4/2/2026, 5:36:15 PM)

43.58

-0.37 (-0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners45.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.55B
Revenue(TTM)22.68B
Net Income(TTM)1.14B
Analysts85.22
Price Target57.32 (31.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)1.68%
PT rev (3m)3.67%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)2.1%
EPS NY rev (1m)-2.82%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 13.62
Fwd PE 11.72
P/S 1.1
P/FCF 20.47
P/OCF 11.28
P/B 1.32
P/tB 13.25
EV/EBITDA 9.67
EPS(TTM)3.2
EY7.34%
EPS(NY)3.72
Fwd EY8.53%
FCF(TTM)2.13
FCFY4.88%
OCF(TTM)3.87
OCFY8.87%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.84
PEG (5Y)N/A
Graham Number48.79
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 4.44%
ROICexc 5.05%
ROICexgc 11.76%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2
F-Score7
WACC5.2%
ROIC/WACC0.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
EPS Next Y16.18%
EPS Next 2Y13.43%
EPS Next 3Y11.88%
EPS Next 5Y10.54%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%
Revenue Next Year4.95%
Revenue Next 2Y4.9%
Revenue Next 3Y5.06%
Revenue Next 5Y5.03%
EBIT growth 1Y51.21%
EBIT growth 3Y7.94%
EBIT growth 5Y-11.93%
EBIT Next Year54.49%
EBIT Next 3Y20.57%
EBIT Next 5Y14.27%
FCF growth 1Y-43.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.77%
OCF growth 3YN/A
OCF growth 5YN/A

FRESENIUS SE & CO KGAA / FRE.DE Fundamental Analysis FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


What is the profitability of FRE stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the valuation of FRESENIUS SE & CO KGAA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 13.62 and the Price/Book (PB) ratio is 1.32.


How financially healthy is FRESENIUS SE & CO KGAA?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.